Default: EMBO Molecular Medicine

ISSN: 1757-4676

Journal Home

Journal Guideline

EMBO Molecular Medicine Q1 Unclaimed

Springer United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

EMBO Molecular Medicine is a journal indexed in SJR in Molecular Medicine with an H index of 142. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 3300 €. The scope of the journal is focused on molecular medicine, molecular pathology, genetic processes, regenerative medicine, systems medicine, molecular biology. It has an SJR impact factor of 3,964 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,964.

EMBO Molecular Medicine focuses its scope in these topics and keywords: als, ftd, cell, approach, spectrum, vulnerability, phenotypes, proteomic, resolves, network, ...

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Price

3300 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

EMBO Molecular Medicine

3,964

SJR Impact factor

142

H Index

165

Total Docs (Last Year)

440

Total Docs (3 years)

9076

Total Refs

3842

Total Cites (3 years)

381

Citable Docs (3 years)

8.2

Cites/Doc (2 years)

55.01

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


als, ftd, cell, approach, spectrum, vulnerability, phenotypes, proteomic, resolves, network, genetic, disease, human, clinical, glycogen, hegemann, effects, editing, braingli, cancer, cells, cholesterol, cognition, derived, diseases, distinct, molecular medicine, molecular pathology, genetic processes, regenerative medicine, systems medicine, molecular biology



Best articles by citations

PHD

View more

Therapeutic repair for spinal cord injury: combinatory approaches to address a multifaceted problem

View more

VEGF

View more

Microparticle alpha-2-macroglobulin enhances pro-resolving responses and promotes survival in sepsis

View more

Inhibiting MARSs reduces hyperhomocysteinemia-associated neural tube and congenital heart defects

View more

Triggering ubiquitination of

View more

A streptococcal lipid toxin induces membrane permeabilization and pyroptosis leading to fetal injury

View more

Fusion protein of retinol-binding protein and albumin domain

View more

Block of K

View more

Acquisition of chromosome instability is a mechanism to evade oncogene addiction

View more

Low-dose

View more

Correction of beta-thalassemia major by gene transfer in haematopoietic progenitors of pediatric patients

View more
SHOW MORE ARTICLES

Inducing mitophagy in diabetic platelets protects against severe oxidative stress

View more

Alterations in cardiac DNA methylation in human dilated cardiomyopathy

View more

Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response

View more

Genome-wide identification and functional analyses of micro

View more

STAT3 activity is necessary and sufficient for the development of immune-mediated myocarditis in mice and promotes progression to dilated cardiomyopathy

View more

Anti-tumor effects of

View more

Coenzyme Q deficiency causes impairment of the sulfide oxidation pathway

View more

Innovation and competition in advanced therapy medicinal products

View more

A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases

View more

ZNF703gene amplification at 8p12 specifies luminal B breast cancer

View more

Vulnerability of invasive glioblastoma cells to lysosomal membrane destabilization

View more

FAQS